The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Monoclonal Antibody Development Services Market Research Report 2024
Synopsis
Monoclonal antibody development services are antibody preparation services tailored to the specific needs of clients. The goal is to generate highly specific and affinity matured monoclonal antibodies for the detection and analysis of specific target molecules. These services are typically provided by specialized antibody development companies, where clients can provide their target antigen or receive guidance to select the most appropriate antigen. The service usually includes immunization of animals with the antigen, hybridoma fusion and screening for monoclonal antibodies, and validation and purification of the monoclonal antibodies. These monoclonal antibodies can be used for various applications, such as immunohistochemistry, immunoblotting, immunoprecipitation, flow cytometry, ELISA, and more.
Global Monoclonal Antibody Development Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monoclonal Antibody Development Services market research.
Key companies engaged in the Monoclonal Antibody Development Services industry include Eurogentec, ProSci, Syd Labs, Promab, Antibodies Inc, Bhat Biotech, Synaptic Systems, Covalab and CePower, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Monoclonal Antibody Development Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Monoclonal Antibody Development Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Monoclonal Antibody Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eurogentec
ProSci
Syd Labs
Promab
Antibodies Inc
Bhat Biotech
Synaptic Systems
Covalab
CePower
Lampire Biological Laboratories
Leinco Technologies
Medimabs
Davids Bioengineering
Scantibodies
Abwiz Bio
Thermo Fisher Scientific
Segment by Type
Small-scale
Medium-sclae
Large-scale
Segment by Application
Biopharmaceuticals
Medical Diagnosis
Agricultural
Medical Treatment
Environmental monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Monoclonal Antibody Development Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Monoclonal antibody development services are antibody preparation services tailored to the specific needs of clients. The goal is to generate highly specific and affinity matured monoclonal antibodies for the detection and analysis of specific target molecules. These services are typically provided by specialized antibody development companies, where clients can provide their target antigen or receive guidance to select the most appropriate antigen. The service usually includes immunization of animals with the antigen, hybridoma fusion and screening for monoclonal antibodies, and validation and purification of the monoclonal antibodies. These monoclonal antibodies can be used for various applications, such as immunohistochemistry, immunoblotting, immunoprecipitation, flow cytometry, ELISA, and more.
Global Monoclonal Antibody Development Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monoclonal Antibody Development Services market research.
Key companies engaged in the Monoclonal Antibody Development Services industry include Eurogentec, ProSci, Syd Labs, Promab, Antibodies Inc, Bhat Biotech, Synaptic Systems, Covalab and CePower, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Monoclonal Antibody Development Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Monoclonal Antibody Development Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Monoclonal Antibody Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eurogentec
ProSci
Syd Labs
Promab
Antibodies Inc
Bhat Biotech
Synaptic Systems
Covalab
CePower
Lampire Biological Laboratories
Leinco Technologies
Medimabs
Davids Bioengineering
Scantibodies
Abwiz Bio
Thermo Fisher Scientific
Segment by Type
Small-scale
Medium-sclae
Large-scale
Segment by Application
Biopharmaceuticals
Medical Diagnosis
Agricultural
Medical Treatment
Environmental monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Monoclonal Antibody Development Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Development Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Small-scale
1.2.3 Medium-sclae
1.2.4 Large-scale
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Development Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biopharmaceuticals
1.3.3 Medical Diagnosis
1.3.4 Agricultural
1.3.5 Medical Treatment
1.3.6 Environmental monitoring
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Development Services Market Perspective (2018-2029)
2.2 Monoclonal Antibody Development Services Growth Trends by Region
2.2.1 Global Monoclonal Antibody Development Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Monoclonal Antibody Development Services Historic Market Size by Region (2018-2023)
2.2.3 Monoclonal Antibody Development Services Forecasted Market Size by Region (2024-2029)
2.3 Monoclonal Antibody Development Services Market Dynamics
2.3.1 Monoclonal Antibody Development Services Industry Trends
2.3.2 Monoclonal Antibody Development Services Market Drivers
2.3.3 Monoclonal Antibody Development Services Market Challenges
2.3.4 Monoclonal Antibody Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Development Services Players by Revenue
3.1.1 Global Top Monoclonal Antibody Development Services Players by Revenue (2018-2023)
3.1.2 Global Monoclonal Antibody Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Monoclonal Antibody Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Development Services Revenue
3.4 Global Monoclonal Antibody Development Services Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Development Services Revenue in 2022
3.5 Monoclonal Antibody Development Services Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Development Services Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Development Services Breakdown Data by Type
4.1 Global Monoclonal Antibody Development Services Historic Market Size by Type (2018-2023)
4.2 Global Monoclonal Antibody Development Services Forecasted Market Size by Type (2024-2029)
5 Monoclonal Antibody Development Services Breakdown Data by Application
5.1 Global Monoclonal Antibody Development Services Historic Market Size by Application (2018-2023)
5.2 Global Monoclonal Antibody Development Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Monoclonal Antibody Development Services Market Size (2018-2029)
6.2 North America Monoclonal Antibody Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Monoclonal Antibody Development Services Market Size by Country (2018-2023)
6.4 North America Monoclonal Antibody Development Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Development Services Market Size (2018-2029)
7.2 Europe Monoclonal Antibody Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Monoclonal Antibody Development Services Market Size by Country (2018-2023)
7.4 Europe Monoclonal Antibody Development Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Development Services Market Size (2018-2029)
8.2 Asia-Pacific Monoclonal Antibody Development Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Monoclonal Antibody Development Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Monoclonal Antibody Development Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Development Services Market Size (2018-2029)
9.2 Latin America Monoclonal Antibody Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Monoclonal Antibody Development Services Market Size by Country (2018-2023)
9.4 Latin America Monoclonal Antibody Development Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Development Services Market Size (2018-2029)
10.2 Middle East & Africa Monoclonal Antibody Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Monoclonal Antibody Development Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Monoclonal Antibody Development Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurogentec
11.1.1 Eurogentec Company Detail
11.1.2 Eurogentec Business Overview
11.1.3 Eurogentec Monoclonal Antibody Development Services Introduction
11.1.4 Eurogentec Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.1.5 Eurogentec Recent Development
11.2 ProSci
11.2.1 ProSci Company Detail
11.2.2 ProSci Business Overview
11.2.3 ProSci Monoclonal Antibody Development Services Introduction
11.2.4 ProSci Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.2.5 ProSci Recent Development
11.3 Syd Labs
11.3.1 Syd Labs Company Detail
11.3.2 Syd Labs Business Overview
11.3.3 Syd Labs Monoclonal Antibody Development Services Introduction
11.3.4 Syd Labs Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.3.5 Syd Labs Recent Development
11.4 Promab
11.4.1 Promab Company Detail
11.4.2 Promab Business Overview
11.4.3 Promab Monoclonal Antibody Development Services Introduction
11.4.4 Promab Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.4.5 Promab Recent Development
11.5 Antibodies Inc
11.5.1 Antibodies Inc Company Detail
11.5.2 Antibodies Inc Business Overview
11.5.3 Antibodies Inc Monoclonal Antibody Development Services Introduction
11.5.4 Antibodies Inc Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.5.5 Antibodies Inc Recent Development
11.6 Bhat Biotech
11.6.1 Bhat Biotech Company Detail
11.6.2 Bhat Biotech Business Overview
11.6.3 Bhat Biotech Monoclonal Antibody Development Services Introduction
11.6.4 Bhat Biotech Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.6.5 Bhat Biotech Recent Development
11.7 Synaptic Systems
11.7.1 Synaptic Systems Company Detail
11.7.2 Synaptic Systems Business Overview
11.7.3 Synaptic Systems Monoclonal Antibody Development Services Introduction
11.7.4 Synaptic Systems Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.7.5 Synaptic Systems Recent Development
11.8 Covalab
11.8.1 Covalab Company Detail
11.8.2 Covalab Business Overview
11.8.3 Covalab Monoclonal Antibody Development Services Introduction
11.8.4 Covalab Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.8.5 Covalab Recent Development
11.9 CePower
11.9.1 CePower Company Detail
11.9.2 CePower Business Overview
11.9.3 CePower Monoclonal Antibody Development Services Introduction
11.9.4 CePower Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.9.5 CePower Recent Development
11.10 Lampire Biological Laboratories
11.10.1 Lampire Biological Laboratories Company Detail
11.10.2 Lampire Biological Laboratories Business Overview
11.10.3 Lampire Biological Laboratories Monoclonal Antibody Development Services Introduction
11.10.4 Lampire Biological Laboratories Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.10.5 Lampire Biological Laboratories Recent Development
11.11 Leinco Technologies
11.11.1 Leinco Technologies Company Detail
11.11.2 Leinco Technologies Business Overview
11.11.3 Leinco Technologies Monoclonal Antibody Development Services Introduction
11.11.4 Leinco Technologies Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.11.5 Leinco Technologies Recent Development
11.12 Medimabs
11.12.1 Medimabs Company Detail
11.12.2 Medimabs Business Overview
11.12.3 Medimabs Monoclonal Antibody Development Services Introduction
11.12.4 Medimabs Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.12.5 Medimabs Recent Development
11.13 Davids Bioengineering
11.13.1 Davids Bioengineering Company Detail
11.13.2 Davids Bioengineering Business Overview
11.13.3 Davids Bioengineering Monoclonal Antibody Development Services Introduction
11.13.4 Davids Bioengineering Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.13.5 Davids Bioengineering Recent Development
11.14 Scantibodies
11.14.1 Scantibodies Company Detail
11.14.2 Scantibodies Business Overview
11.14.3 Scantibodies Monoclonal Antibody Development Services Introduction
11.14.4 Scantibodies Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.14.5 Scantibodies Recent Development
11.15 Abwiz Bio
11.15.1 Abwiz Bio Company Detail
11.15.2 Abwiz Bio Business Overview
11.15.3 Abwiz Bio Monoclonal Antibody Development Services Introduction
11.15.4 Abwiz Bio Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.15.5 Abwiz Bio Recent Development
11.16 Thermo Fisher Scientific
11.16.1 Thermo Fisher Scientific Company Detail
11.16.2 Thermo Fisher Scientific Business Overview
11.16.3 Thermo Fisher Scientific Monoclonal Antibody Development Services Introduction
11.16.4 Thermo Fisher Scientific Revenue in Monoclonal Antibody Development Services Business (2018-2023)
11.16.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
